Data presented in Figuresare mean SEM. diet or Triptorelin Acetate an iron-deficient diet for 9 days before death, or for 7 Smad3 days before a 24- to 48-hour starvation period; liver and spleen tissues then were collected and analyzed by quantitative reverse-transcription polymerase chain reaction and immunoblot analyses. Serum levels of iron, hemoglobin, Hepcidin, and glucose also were measured. We analyzed human hepatoma (HepG2) cells and mouse main hepatocytes to study transcriptional control ofHamp(the gene that encodes Hepcidin) in response to gluconeogenic stimuli using small interfering RNA, luciferase promoter, and chromatin immunoprecipitation analyses. == Results == Starvation led to increased transcription of the gene that encodes phosphoenolpyruvate carboxykinase 1 (a protein involved in gluconeogenesis) in livers of mice, increased levels of Hepcidin, and degradation of Ferroportin, compared with nonstarved mice. These changes resulted in hypoferremia and iron retention in liver tissue. Livers of starved mice also experienced increased levels ofPpargc1amRNA andCreb3l3mRNA, which encode a transcriptional co-activator involved in energy metabolism and a liver-specific transcription factor, respectively. Glucagon and a cyclic adenosine monophosphate analog increased promoter activity and transcription ofHampin cultured liver cells; levels ofHampwere reduced after administration of small interfering RNAs againstPpargc1aandCreb3l3. PPARGC1A and CREB3L3 bound the Hamp promoter to activate its transcription in response to a cyclic adenosine monophosphate analog.Creb3l3/ mice did not up-regulateHampor become hypoferremic during starvation. == Conclusions == We recognized a link between glucose and iron homeostasis, showing that Hepcidin is usually a gluconeogenic sensor in mice during starvation. This response is usually involved in hepatic metabolic adaptation to increased energy demands; it preserves tissue iron for vital activities during food withdrawal, but can cause excessive iron retention and hypoferremia in disorders with persistently activated gluconeogenesis and insulin resistance. Keywords:Peroxisome Proliferator-Activated Receptor-Gamma Co-activator 1-Alpha (PGC1A), cAMP Response Element-Binding Protein-H (CREBH), Glucagon, Mouse Model Abbreviations used in this paper:cAMP, cyclic adenosine monophosphate; ChIP, chromatin immunoprecipitation; CREBBL3/CREBH, cyclic adenosine monophosphate response element binding protein 3like 3; ER, endoplasmic reticulum; FPN1, ferroportin; HAMP, hepcidin; IL, interleukin; NAFLD, nonalcoholic fatty liver disease; Pck1, phosphoenolpyruvate carboxykinase 1; PPARGC1A, peroxisome proliferator-activated receptor gamma coactivator 1-; qRT-PCR, quantitative reverse-transcription polymerase chain reaction; siRNA, small interfering RNA Adaptation to different says, such as exercise, rest, and starvation or overnutrition, is essential for Triptorelin Acetate life. In turn, dysfunction and perturbation of these networks can lead to metabolic imbalances, which if uncorrected induce diseases Triptorelin Acetate such as obesity or diabetes. Metabolic adaptation is largely controlled by transcriptional co-regulators and transcription factors responsible, respectively, for sensing metabolic disturbances and fine-tuning the transcriptional response.1During starvation, this adaptive response is essential for species survival, and the liver plays a central role in this process as a main site for gluconeogenesis and energy production.2At early stages, the liver mobilizes glucose from its glycogen stores; as fasting progresses, it oxidizes excess fat to provide Triptorelin Acetate both energy for gluconeogenesis and substrate for ketogenesis. Generation of sugar from nonsugar carbon substrates (gluconeogenesis) entails several enzyme-catalyzed reactions that take place in both cytosol and mitochondria. Iron is essential for vital redox activities in the cell, in particular it is required for respiration and energy production in mitochondria (which are also the unique site for heme synthesis and the major site for Fe-S cluster biosynthesis), and likewise is usually important for mitochondria biogenesis. 3A quantity of iron abnormalities, ranging from low serum iron/iron-restricted anemia to hepatic/systemic iron overload, have been reported in human disorders with activated gluconeogenic signaling pathways, including obesity,4metabolic syndrome,5,6,7and diabetes.8,9Interestingly, iron excess has been associated with worsened insulin sensitivity and disease progression, whereas iron removal has been found to be beneficial.6,8,10Based on these premises, we asked whether iron status could be regulated directly by gluconeogenic signals. Systemic and local iron status are under the control of hepcidin, a defensin-like circulating peptide that degrades the iron exporter ferroportin (FPN1), thereby dictating the extent of iron release or retention in the cell.11Hepcidin expression is transcriptionally controlled by a number of factors that deliver the relevant stimulatory or inhibitory signals to the nuclear machinery and turn on or off the hepcidin (HAMP) gene. The main stimulatory transcription factors include small mother against decapentaplegic (SMAD) proteins, which bind the bone morphogenetic protein responsive element and deliver the iron transmission,12,13STAT-3, mainly involved in the inflammatory transmission,14,15,16and cyclic adenosine monophosphate (cAMP) response element binding protein 3like 3, CREB3L3 (also known as CREBH), more recently found to mediate hepcidin induction by endoplasmic reticulum.
